Publications by authors named "Negar Yaghobi"
Article Synopsis
- Hydroxyurea (HU) has been effectively used since 1996 to treat patients with non transfusion-dependent β-thalassemia major at a research center in Iran, with experience shared through a review of patient records.
- The study focused on key metrics including hemoglobin levels before and after HU treatment, age at first transfusion, and the overall reduction in blood transfusion needs, indicating significant positive outcomes.
- The results showed that HU is not only effective but also safe, leading to a recommendation for its continued use in managing non transfusion-dependent β-TM.
